European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

4 EU fundings (€0.00): Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies … BdlYear 2019 EU Research and Innovation programme "Horizon"

Text

Merck Sharp & Dohme Corp., Rahway, United States

01/12/2019 EU funding (€11M): Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies
01/02/2019 EU funding (€14M): Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
01/03/2019 EU funding (€5,331,000): Neurotoxicity De-Risking in Preclinical Drug Discovery
01/01/2019 EU funding (€5,499,882): Vaccines and Infectious Diseases in the Ageing PopuLation

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Merck Sharp & Dohme Corp., Rahway, United States.

Printing is only available to North Data premium service subscribers.